Case Study: Leading Pharma Company Achieves Successful Orphan Drug Launch Strategy with Axtria

Developing Product Launch Strategy For An Orphan Drug For A Specialty Pharma

Leading Pharma Company, a specialty pharma business, was preparing to launch a novel orphan drug for a rare disease but faced major uncertainty around the target population, top treaters, and patient treatment journey. With limited disease knowledge, frequent misdiagnosis, and few comparable analogs, the company turned to Axtria for help defining its launch strategy.

Axtria developed a go-to-market strategy that included sales force sizing and structure, segmentation and targeting, and alignment recommendations. By analyzing the patient treatment journey and HCP value, Axtria enabled efficient targeting of the precise patient pool, identified key thought leaders, and created a robust execution plan to improve coverage of priority and opportunistic targets.